CNBC December 17, 2024
Ashley Capoot

Key Points

– Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose.

– The company has been building a generative AI platform with technology from Google Cloud.

– The report breaks down how Stelo users’ meals, sleep and activity impact their glucose levels, and it includes relevant tips and educational materials.

Dexcom on Tuesday announced an artificial intelligence feature for its Stelo continuous glucose monitor that gives users a personalized look into how meals, sleep and activity impact their glucose levels. It’s the first iteration of a new generative AI platform that the company has been building with Google Cloud.

Stelo is an over-the-counter...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, Patient / Consumer, Provider, Technology, Wearables
AI Threatens To Further Erode Physician Autonomy
Four forces shaping healthcare in 2025
8 Way AI Can Optimize Revenue Cycle Management in 2025
A Marathon Of Innovation: 4 AI Technologies To Watch In 2025
Guardant Health and ConcertAI Partner to Unlock Cancer Insights with Multi-Modal Real-World Data

Share This Article